Carbon dioxide hydrate as a recovery tool after fatigue of the plantar flexors.
Cryotherapy
Evoked torque
Icing
Repeated contractions
Voluntary activation
Journal
Journal of biomechanics
ISSN: 1873-2380
Titre abrégé: J Biomech
Pays: United States
ID NLM: 0157375
Informations de publication
Date de publication:
17 07 2020
17 07 2020
Historique:
received:
16
02
2020
revised:
10
06
2020
accepted:
14
06
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
This study investigated the effects of cooling the triceps surae with carbon dioxide hydrate (CDH), which is a gas hydrate, a crystalline structure belonging to the clathrates, on the recovery from muscle fatigue. Thirty-six healthy young men were equally and randomly assigned to an ICE group, a CDH group, or a non-cooling (NON) group. All participants performed 80 maximal voluntary isometric contractions (MVCs) of the plantar flexors as a fatiguing task. MVC torque and voluntary activation were determined before, immediately after, and 20 min after the fatiguing task. Evoked torque was similarly assessed except for immediately after the task. In the ICE and CDH groups, the triceps surae was cooled for 5 min using ice and CDH, starting 5 min after the fatiguing task, respectively. The MVC torque and voluntary activation were higher in order of before >20 min after >immediately after the fatiguing task regardless of group, and those time-course changes did not differ between the groups. A decrease in the evoked torque from before to 20 min after the fatiguing task was observed in the ICE and NON groups but not in the CDH group. These results suggest that cooling muscle with CDH can facilitate recovery from peripheral muscle fatigue. This may be due to an increase in blood flow caused by carbon dioxide contained within the CDH, and indicates the potential of CDH as a recovery tool after fatiguing exercise.
Identifiants
pubmed: 32636011
pii: S0021-9290(20)30323-7
doi: 10.1016/j.jbiomech.2020.109900
pii:
doi:
Substances chimiques
Carbon Dioxide
142M471B3J
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109900Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Ryota Akagi received a research fund for this study from Kirin Holdings Company, Limited. Yoshihiko Sugihara and Hiroyuki Murakami are employees of Kirin Holdings Company, Limited.